Lupus Day 2 Highlights: Drs Dao , Mehta, Yusof, Pope, Reyes and Castillo review lupus-related information and data presented during day 2 of the #ACR21 annual meeting. https://t.co/QX6Ay77FKo @KDAO2011 @bella_mehta @Yuz6Yusof @Janetbirdope @RHEUMarampa @_Castillo_Pedro https://t.co/ldAHqXsi0G

• https://bit.ly/3c3WlNd

RA: Cardiovascular Risk Stratification and Potential Predictors of Risk Dr. El Ramahi ( @MeralElRamahiMD ) shares important takeaways from abstracts presented at #ACR21. https://t.co/69E7aA0Wag https://t.co/6nR5TLeyga

• https://bit.ly/3c2lvf8

Spondyloarthritis Roundtable Rehash of #ACR21 New therapies, delay in diagnosis, artificial intelligence in reading radiographs and MRIs, and more. Panelists includes Dr. Alexis Ogdie-Beatty, Dr. Jose Scher, Dr. Jack Cush and Dr. Christopher Ritchlin. https://t.co/K0pbddzLAF https://t.co/fS6wBNWOdJ

• https://bit.ly/31VrIYu

Day 4 Report from #ACR21 My favorite three presentations from day 4 at ACR 2021 included the following: -Breakthrough Infections in Rheumatic Disease Patients -Secukinumab in Giant Cell Arteritis -STOP-Gout – Febuxostat is Noninferior to Allopurinol https://t.co/zJRS5AHjc1 https://t.co/FuwCFCK14r

• https://bit.ly/3wzDrHc

Cognitive Impairment in Patients with Rheumatoid Arthritis Dr. Akhil Sood ( @AkhilSoodMD) discusses abstracts presented at #ACR21. https://t.co/zz8auqZjIW https://t.co/RSHjyonBrj

• https://bit.ly/3C7QJvM

Predictors to Flare in SpA: Dr. Antoni Chan ( @synovialjoints ) discusses abstracts #0929 and #0916 presented at the #ACR21 annual meeting. https://t.co/C0NLSTzlW9 https://t.co/3BiW2L6BJu

• https://bit.ly/3D4xx3z

Can we Use Frax Score in RA Patients? Dr. Eric Dein ( @ejdein1) reviews abstract #0563 presented at the #ACR21 annual meeting. https://t.co/UcvTWhlcvW https://t.co/8AdHa2enlz

• https://bit.ly/30ili5c

An Exclusive Interview with Dr. Al Kim (#Wowkim): Dr. Kathryn Dao ( @KDAO2011 ) interviews Dr. Alfred Kim (aka #Wowkim) about the exciting work he's presenting at the #ACR21 annual meeting. https://t.co/34EZIz2OFG https://t.co/mhaUcIhTKu

• https://bit.ly/30bfs5K

ACR21 Best Abstracts - Day 4 On the last day of #ACR21 Annual Meeting, the RheumNow faculty selected their favorite reports. Follow the link below for our selections! https://t.co/O6IXf5iB3d https://t.co/G1yUzqwcuk

• https://bit.ly/3qpEpox

Predictors of Remission and Low Disease Activity in SLE Dr. Sheila Reyes ( @RHEUMarampa) shares results of abstracts discussed at #ACR21. https://t.co/FayzgyGiP8 https://t.co/QvKbKnznmS

• https://bit.ly/3n2kzxq

Serum Biomarkers Distinguish Radiographic Progression in PsA: Dr. Robert Chao ( @doctorRBC ) discusses abstract #0449 presented at the #ACR21 annual meeting. https://t.co/Q9JQyx7K1A

Emapalumab for the treatment of macrophage activation syndrome Dr. Yuz Yusof ( @Yuz6Yusof) summarizes abstracts presented at #ACR21. https://t.co/TXdbwA64wg https://t.co/VLiLIsEkxS

• https://bit.ly/3wBDRwJ

Predictors of mortality in RA lung disease? Dr. Meral El Ramahi ( @MeralElRamahiMD) discusses abstract #0290 presented at the #ACR21 annual meeting. https://t.co/swo0eexWHl https://t.co/dVpeTQIwTb

• https://bit.ly/3C3TGNW

Depression in Axial Spondyloarthritis: Dr. Mrinalini Dey ( @DrMiniDey) discusses abstract #1305 presented at the #ACR21 annual meeting. https://t.co/KUGM61fpZK https://t.co/YhyvGUJkO0

• https://bit.ly/3D4RION

#ACR21 – Day 3 Report Day 3 presentations were big! We share a few of our favorites. https://t.co/UfWIFq2lWb https://t.co/Z8VKGXvPzz

• https://bit.ly/30eowWM